• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameVISX STAR EXCIMER LASER SYSTEM
Classification Nameexcimer laser system
Generic Nameexcimer laser for ophthalmic use
ApplicantVISX, INCORPORATED
PMA NumberP930016
Supplement NumberS012
Date Received07/14/2000
Decision Date04/27/2001
Product Code
LZS[ Registered Establishments with LZS ]
Docket Number 01M-0305
Notice Date 07/23/2001
Advisory Committee Ophthalmic
Supplement Typepanel track
Supplement Reason labeling change - indications
Expedited Review Granted? Yes
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the visx star s2 and s3 excimer laser systems. The devices are indicated for laser in-situ keratomileusis (lasik) treatments: 1) in patients with documented evidence of a change in manifest refraction of no more than 0. 5 d (in both cylinder and sphere components) for at least one year prior to the date of pre-operative examination; and 2) in patients 21 years of age or older in treatments for the reduction of elimination of naturally occurring hyperopia between +05 and +5. 0 d sphere at the spectacle plane with or without refractive astigmatism up to +3. 0 d, with a maximum manifest refraction spherical equivalent (mrse) of +6. 0 d.
Approval Order Approval Order
-
-